1. Home
  2. GDTC vs BNKK Comparison

GDTC vs BNKK Comparison

Compare GDTC & BNKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

HOLD

Current Price

$0.91

Market Cap

10.4M

Sector

Health Care

ML Signal

HOLD

BNKK

Bonk Inc.

HOLD

Current Price

$1.42

Market Cap

10.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDTC
BNKK
Founded
2018
2018
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.4M
10.6M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
GDTC
BNKK
Price
$0.91
$1.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.4K
★ 98.9K
Earning Date
04-24-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $2,117,309.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 201.63
52 Week Low
$0.68
$0.11
52 Week High
$3.68
$7.19

Technical Indicators

Market Signals
Indicator
GDTC
BNKK
Relative Strength Index (RSI) 51.48 57.57
Support Level $0.73 $1.41
Resistance Level $1.08 $1.47
Average True Range (ATR) 0.09 0.11
MACD 0.01 0.01
Stochastic Oscillator 67.31 70.86

Price Performance

Historical Comparison
GDTC
BNKK

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About BNKK Bonk Inc.

Bonk Inc provides over-the-counter products and consumer products in the United States. The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content. It sells its products through direct customers, distributors, retailers, and e-commerce websites. The company generates revenue through various channels, its primary sales include nostingz suncare products which are sold through e-commerce platforms, licensing revenues from Photocil and sales of the Safety Shot Beverage. The company has two reportable segments: the dietary and energy beverage business and digital assets, consisting of investing for growth in the appreciation of the asset. It derives the majority of the revenue from the dietary and energy beverage segment.

Share on Social Networks: